SEARCH

SEARCH BY CITATION

References

  • 1
    Hamer DH, Connor BA. Travel health knowledge, attitudes and practices among United States travellers. J Travel Med 2004; 11:2326.
  • 2
    Toovey S, Jamieson A, Holloway M. Travellers’ knowledge, attitudes and practices on the prevention of infectious diseases: results from a study at Johannesburg International Airport. J Travel Med 2004; 11:1622.
  • 3
    Wilder-Smith A, Khairullah NS, Song JH, et al. Travel health knowledge, attitudes and practices among Australian travellers. J Travel Med 2004; 11:915.
  • 4
    Van Herck K, Van Damme P, Castelli F, et al. Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey. J Travel Med 2004; 11:38.
  • 5
    Van Herck K, Kuckerman J, Castelli F, et al. Travellers’ knowledge, attitudes and practices on prevention of infectious diseases: results from a pilot study. J Travel Med 2003; 10:7578.
  • 6
    Decree March 17, 1995, N. 111. Endorsement of Directive N. 90/314/CEE regarding travels, holidays and ‘all inclusive’ packages. Gazzetta Ufficiale della Repubblica Italiana April 14, 1995, n.88.
  • 7
    Total number of travellers crossing the borders by area. Ufficio Italiano dei Cambi. Available at: http://www.uic.it/UICFEWebroot. (Accessed 7 February 2006)
  • 8
    Total number of passengers. Florence Airport. Available at: http://www.aeroporto.firenze.it/. (Accessed 7 February 2006)
  • 9
    Total number of international passengers. Pisa International Airport. Available at: http://www.pisa-airport.com/. (Accessed 7 February 2006)
  • 10
    International travel and health, World Health Organization, 2005. Available at: http://www.who.int/ith/en. (Accessed 2 February 2006)
  • 11
    Overbosch D, Schilthuis H, Bienzle U, et al. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study. Clin Infect Dis 2001; 33:10151021.
  • 12
    Hogh B, Clarke PD, Camus D, et al. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Lancet. 2000; 356:18881894.
  • 13
    Schlagenhauf P, Tschopp A, Johnson R, et al. Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study. BMJ 2003; 327:1078.
  • 14
    Petersen E, Ronne T, Ronn A, et al. Reported side effects to chloroquine, chloroquine plus proguanil, and mefloquine as chemoprophylaxis against malaria in Danish travelers. J Travel Med 2000; 7:7984.
  • 15
    Lobel HO, Baker MA, Gras FA, et al. Use of malaria prevention measures by North American and European travellers to East Africa. J Travel Med 2001; 8:167172.
  • 16
    Laver SM, Wetzels J, Behrens RH. Knowledge of malaria, risk perception, and compliance with prophylaxis and personal and environmental preventive measures in travellers existing Zimbabwe from Harare and Victoria Falls International Airport. J Travel Med 2001;8:298303.
  • 17
    Mattila L, Siitonen A, Kyronseppa H, et al. Risk behavior for travelers’ diarrhea among finnish travelers. J Travel Med 1995; 2:7784.
  • 18
    Rack J, Wichmann O, Kamara B, et al. Risk and spectrum of diseases in travelers to popular tourist destinations. J Travel Med 2005; 12:248253.
  • 19
    Steffen R, Tornieporth N, Clemens SA, et al. Epidemiology of travelers’ diarrhea: details of a global survey. J Travel Med 2004; 11:231237.
  • 20
    Al-Abri SS, Beeching NJ, Nye FJ. Traveller’s diarrhoea. Lancet Infect Dis 2005; 5:349360.
  • 21
    Peetermans WE, Van Wijngaerden E. Implementation of pretravel advice: good for malaria, bad for diarrhoea. Acta Clin Belg 2001; 56:284288.
  • 22
    Ericsson CD. Travellers’ diarrhoea. Int J Antimicrob Agents 2003; 21:116124.